Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.24

€0.24

-4.880%
-0.012
-4.880%
-
 
18.06.25 / Tradegate WKN: A0JMA0 / Name: EnWave / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...

Enwave Corporation Stock

Heavy losses for Enwave Corporation today as the stock fell by -€0.012 (-4.880%).

Pros and Cons of Enwave Corporation in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Enwave Corporation vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Enwave Corporation -4.880% 1.667% 22.613% 47.879% 63.758% -48.360% -51.200%
Resverlogix Corp -11.630% -7.317% -22.449% -38.710% -29.630% -89.385% -95.476%
Xenon Pharmaceuticals Inc. -1.440% -2.113% -0.714% -17.751% -24.457% -11.465% -
Fennec Pharmaceuticals Inc. -2.220% -2.222% -8.333% 8.197% 12.821% 28.155% -18.012%

News

EnWave Signs License Amendment with Procescir S.A. de C.V. to Expand Product Portfolio; Sells Auxiliary REV-related Equipment
EnWave Signs License Amendment with Procescir S.A. de C.V. to Expand Product Portfolio; Sells Auxiliary REV-related Equipment

Vancouver, B.C., June 11th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed an amendment ( the “Amendment”) to the

EnWave Reports 2025 Second Quarter Consolidated Interim Financial Results
EnWave Reports 2025 Second Quarter Consolidated Interim Financial Results

Vancouver, B.C., May 22nd, 2025. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the second

EnWave Signs License Amendment with Creations Foods to Expand License to Include Pet Treat Applications
EnWave Signs License Amendment with Creations Foods to Expand License to Include Pet Treat Applications

Vancouver, B.C., May 20th, 2025, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed an amendment ( the “Amendment”) regarding the